DocGo Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
DocGo Inc. (DCGO) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 16.47 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-17
- DocGo Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 16.47M shares, a 23.49% increase year-over-year.
- DocGo Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 16.89M shares, a 136.86% increase year-over-year.
- DocGo Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 13.80M shares, a 89.88% increase year-over-year.
- DocGo Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 13.34M shares, a 78.17% increase year-over-year.
- DocGo Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 17.92M shares, a 147.07% increase from fiscal 2024.
- DocGo Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 7.25M shares, a 31.84% decline from fiscal 2023.
- DocGo Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 10.64M shares, a 18.19% increase from fiscal 2022.
- DocGo Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 9.00M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 16.47M shares 10-Q · filed 2026-08-17 | 16.47M shares 10-Q · filed 2026-08-17 | |||
| 2026-03-31 | 16.89M shares 10-Q · filed 2026-05-11 | ||||
| 2025-12-31 | 17.92M shares 10-K · filed 2026-03-16 | ||||
| 2025-09-30 | 13.80M shares 10-Q · filed 2025-11-10 | 13.80M shares 10-Q · filed 2025-11-10 | |||
| 2025-06-30 | 13.34M shares 10-Q · filed 2026-08-17 | 13.34M shares 10-Q · filed 2026-08-17 | |||
| 2025-03-31 | 7.13M shares 10-Q · filed 2026-05-11 | ||||
| 2024-12-31 | 7.25M shares 10-K · filed 2026-03-16 | ||||
| 2024-09-30 | 7.27M shares 10-Q · filed 2025-11-10 | 7.27M shares 10-Q · filed 2025-11-10 | |||
| 2024-06-30 | 7.49M shares 10-Q · filed 2025-08-07 | 7.49M shares 10-Q · filed 2025-08-07 | |||
| 2024-03-31 | 8.68M shares 10-Q · filed 2025-05-08 | ||||
| 2023-12-31 | 10.64M shares 10-K · filed 2026-03-16 | ||||
| 2023-09-30 | 10.19M shares 10-Q · filed 2024-11-07 | 10.19M shares 10-Q · filed 2024-11-07 | |||
| 2023-06-30 | 9.18M shares 10-Q · filed 2024-08-07 | 9.18M shares 10-Q · filed 2024-08-07 | |||
| 2023-03-31 | 9.34M shares 10-Q · filed 2024-05-08 | ||||
| 2022-12-31 | 9.00M shares 10-K · filed 2025-02-27 | ||||
| 2022-09-30 | 0.00 shares 10-Q · filed 2023-11-06 | 0.00 shares 10-Q · filed 2023-11-06 | |||
| 2022-06-30 | 0.00 shares 10-Q · filed 2023-08-08 | 0.00 shares 10-Q · filed 2023-08-08 | |||
| 2022-03-31 | 25.56M shares 10-Q · filed 2022-05-10 | ||||
| 2021-12-31 | 0.00 shares 10-K · filed 2024-02-28 | ||||
| 2021-06-30 | 39.45K shares 10-Q · filed 2022-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |